Skip to main content
. 2010 Oct 4;54(12):5298–5302. doi: 10.1128/AAC.00267-10

TABLE 2.

Percentages of time above the MICs of the free, unbound fractions of tomopenem and meropenem required for their in vivo efficacies

Strain f%TMIC of indicated drug for effects indicateda
Tomopenem
Meropenem
Static (95% CI) 1-log kill (95% CI) 2-log kill (95% CI) Static (95% CI) 1-log kill (95% CI) 2-log kill (95% CI)
P. aeruginosa 12467 29 (25-33) 39 (35-43) 51 (45-58) 24 (21-28) 33 (30-37) 45 (39-52)
MRSA 12372 27 (24-29) 35 (31-37) 47 (39-52) ND ND ND
a

ND, not determined.